Search   
MSDS  : 19-Norpregn-4-ene-3,20-dione, 17-hydroxy-, hexanoate
CAS  : 1253-28-7
SYNONYMS  : * 17-beta-Acetyl-17-hydroxyestr-4-ene-3-one hexanoate * Depostat * Gestonorone caproate * Gestonorone capronate * Gestronol caproate * Gestronol hexanoate * 17-Hydroxy-19-norpregn-4-ene-3,20-dione hexanoate * 17-Hydroxy-19-nor-4-pregnene-3,20-dione hexanoate * 17-alpha-Hexanoyloxy-19-nor-4-pregnene-3,20-dione * 17-alpha-Hydroxy-19-norprogesterone caproate * 19-Norpregn-4-ene-3,20-dione, 17-((1-oxohexyl)oxy)- * 17-((1-Oxohexyl)oxy)-19-norpregn-4-ene-3,20-dione * Primostat * SH 582 * SH 80582
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : RC8960700
CHEMICAL NAME : 19-Norpregn-4-ene-3,20-dione, 17-hydroxy-, hexanoate
CAS REGISTRY NUMBER : 1253-28-7
LAST UPDATED : 199210
DATA ITEMS CITED : 13
MOLECULAR FORMULA : C26-H38-O4
MOLECULAR WEIGHT : 414.64
WISWESSER LINE NOTATION : L E5 B666 OV MUTJ E1 FV1 FOV5
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* 17-beta-Acetyl-17-hydroxyestr-4-ene-3-one hexanoate
* Depostat
* Gestonorone caproate
* Gestonorone capronate
* Gestronol caproate
* Gestronol hexanoate
* 17-Hydroxy-19-norpregn-4-ene-3,20-dione hexanoate
* 17-Hydroxy-19-nor-4-pregnene-3,20-dione hexanoate
* 17-alpha-Hexanoyloxy-19-nor-4-pregnene-3,20-dione
* 17-alpha-Hydroxy-19-norprogesterone caproate
* 19-Norpregn-4-ene-3,20-dione, 17-((1-oxohexyl)oxy)-
* 17-((1-Oxohexyl)oxy)-19-norpregn-4-ene-3,20-dione
* Primostat
* SH 582
* SH 80582

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Gastrointestinal - other changes
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 8,296,1977

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 6800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 13,349,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - other changes
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 8,296,1977

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 400 mg/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay)
Lungs, Thorax, or Respiration - acute pulmonary edema
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 8,296,1977

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Liver - other changes
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 8,296,1977

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Liver - other changes
Blood - changes in spleen
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 8,296,1977

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 13,349,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : >150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 13,349,1982

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3500 mg/kg/28W-I
TOXIC EFFECTS :
Related to Chronic Data - changes in ovarian weight
Related to Chronic Data - changes in prostate weight
Related to Chronic Data - changes in testicular weight
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 9,307,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 12 gm/kg/30D-I
TOXIC EFFECTS :
Liver - changes in liver weight
Related to Chronic Data - changes in prostate weight
Related to Chronic Data - changes in testicular weight
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 9,275,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2520 mg/kg/28W-I
TOXIC EFFECTS :
Related to Chronic Data - changes in ovarian weight
Related to Chronic Data - changes in prostate weight
Related to Chronic Data - changes in testicular weight
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 9,307,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 540 mg/kg/35D-I
TOXIC EFFECTS :
Liver - changes in liver weight
Related to Chronic Data - changes in prostate weight
Related to Chronic Data - changes in testicular weight
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 9,275,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 160 mg/kg/30D-I
TOXIC EFFECTS :
Liver - changes in liver weight
Related to Chronic Data - changes in ovarian weight
Related to Chronic Data - changes in prostate weight
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 9,275,1978

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol,(17-alpha)-, mixt. with (17-alpha)-19-norpregn-4-en-20-yn-17-ol 8064-76-4
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-(cyclopentyloxy)- 152-43-2
19-Norpregna-1,3,5(10)-trien-20-yn-17-ol,3-(cyclopentyloxy)-11-methyl-, (11-beta,17-alpha)- 55648-36-7
Nicotine, 1,1'-dioxide, dihydrochloride, dihydrate 55648-36-7
17-alpha-19-Norpregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy- 72-33-3
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy-, and 6-chloro-17-hydroxypregna-4,6-diene-3,20-dione 72-33-3
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy-, and 21-fluoro-17-hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate 72-33-3
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy-, and 17-hydroxy-6-methyl-pregna-4,6-dien-3-one acetate 72-33-3
19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy-, and 17-hydroxy-19-nor-17-alpha-pregna-4,20-dien-3-one 72-33-3
19-Nor-17-alpha-pregna-4,9,11-trien-20-yn-3-one,17-hydroxy- 848-21-5
19-Norpregna-4,9,11-trien-20-yn-3-one, 17-hydroxy-,oxime, (17-alpha)- 19636-23-8
19-Nor-17-alpha-pregna-4,9,11-trien-20-yn-3-one,17-hydroxy-, and testosterone 19636-23-8
19-Nor-17-alpha-pregn-4-ene-3,17-beta-diol, 3-acetate 101832-66-0
A-Nor-17-alpha-pregn-20-ene-2-beta,17-diol,2-ethynyl-20,21,21-trifluoro- 101832-66-0
Nicotine dustSUBSTANCE DEFINITION :Contains 4% nicotine.REFERENCE :JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-Volume(issue)/page/year: 93,407,1948 101832-66-0
19-Nor-17-alpha-pregn-4-ene-3,17-diol, 3-propionate 101832-66-0
A-Nor-17-alpha-pregn-20-ene-2-beta,17-beta-diol,2-alpha-ethynyl-20,21,21-trifluoro- 52-47-1
19-Norpregn-4-ene-3,20-dione 472-54-8
19-Norpregn-4-ene-3,20-dione,17-(acetyloxy)-11-methyl-, (11-beta)- 25092-41-5
19-Norpregn-4-ene-3,20-dione, 4-chloro- 99950-46-6
19-Norpregn-4-ene-3,20-dione,16-ethyl-21-((1-oxododecyl)oxy)-, (16-alpha)- 67490-00-0
19-Norpregn-4-ene-3,20-dione, 17-alpha-hydroxy-,acetate 67490-00-0
19-Norpregn-4-ene-3,20-dione, 17-hydroxy-, hexanoate 1253-28-7
19-Norpregn-4-ene-3,20-dione,17-hydroxy-16-methylene-, acetate 7759-35-5
19-Norpregn-9-ene-3,20-dione, 5-methyl-, (5-beta)- 130917-92-9
Nicotine, hydrochloride, (-)- 21361-93-3
19-Nor-17-alpha-pregn-4-en-17-ol 965-90-2
19-Nor-17-alpha-pregn-5-en-20-yn-17-ol 16915-71-2
19-Norpregn-17(20)-en-3-one 16915-71-2
19-Nor-17-alpha-pregn-4-en-3-one, 17,21-dihydroxy- 2436-31-9
19-Nor-17-alpha-pregn-4-en-3-one, 17-hydroxy- 52-78-8
19-Nor-17-alpha-pregn-5(10)-en-3-one, 17-hydroxy- 6318-07-6
19-Nor-17-alpha-pregn-4-en-3-one, 17-hydroxy-,acetate 18063-30-4
19-Nor-17-alpha-pregn-4-en-3-one, 17-hydroxy-, andtestosterone 18063-30-4
19-Nor-17-alpha-pregn-4-en-3-one, 17,20(or21),21-trihydroxy- 18063-30-4
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-diol 1231-93-2
Nicotine, hydrochloride, (+)- 69782-38-3
19-Nor-17-alpha-pregn-5(10)-en-20-yne-3-alpha,17-diol 21466-08-0
19-Nor-17-alpha-pregn-5(10)-en-20-yne-3-beta,17-diol 2307-97-3
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-diol,17-acetate 2061-46-3
19-Nor-17-alpha-pregn-4-en-20-yne-3,17-diol,diacetate 6785-71-3
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-dioldiacetate 297-76-7
19-Nor-17-alpha-pregn-5(10)-en-20-yne-3,17-beta-diol,diacetate 101858-17-7
19-Norpregn-4-en-20-yne-3-beta,17-diol, diacetate,mixt. with 3-methoxy-17-alpha-19-norpregna-1,3,5(10)-trien-20-yn-17-ol (5:1) 101858-17-7
19-Nor-17-alpha-pregn-4-en-20-yne-3,17-diol,diacetate, and 3-methoxy-19-nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol 101858-17-7
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-dioldiacetate mixed with 3-methoxy-19-nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol 101858-17-7
19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-diolmixed with 3-methoxy-17-alpha-19-norpregna-1,3,5(10)-trien-20-yn-17-ol 8056-92-6
Nicotine, hydrochloride 2820-51-1
19-Nor-17-alpha-pregn-4-en-20-yn-17-ol 52-76-6
19-Nor-17-alpha-pregn-5(10)-en-20-yn-17-ol,21-chloro- 52-76-6

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net